Andra AP fonden Purchases 105,995 Shares of Waters Corporation $WAT

Andra AP fonden grew its holdings in shares of Waters Corporation (NYSE:WAT) by 1,044.8% in the 3rd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund owned 116,140 shares of the medical instruments supplier’s stock after purchasing an additional 105,995 shares during the quarter. Andra AP fonden owned approximately 0.20% of Waters worth $34,820,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds also recently made changes to their positions in the business. Brighton Jones LLC grew its position in shares of Waters by 112.9% during the 4th quarter. Brighton Jones LLC now owns 1,269 shares of the medical instruments supplier’s stock valued at $471,000 after acquiring an additional 673 shares during the period. Integrated Wealth Concepts LLC raised its holdings in Waters by 2.9% in the 1st quarter. Integrated Wealth Concepts LLC now owns 1,048 shares of the medical instruments supplier’s stock worth $386,000 after purchasing an additional 30 shares during the period. Goldman Sachs Group Inc. lifted its position in Waters by 3.6% during the first quarter. Goldman Sachs Group Inc. now owns 200,051 shares of the medical instruments supplier’s stock valued at $73,733,000 after purchasing an additional 6,976 shares in the last quarter. Empowered Funds LLC grew its holdings in Waters by 16.6% during the first quarter. Empowered Funds LLC now owns 1,126 shares of the medical instruments supplier’s stock valued at $415,000 after purchasing an additional 160 shares during the period. Finally, Sivia Capital Partners LLC purchased a new stake in Waters in the second quarter worth about $232,000. Hedge funds and other institutional investors own 94.01% of the company’s stock.

Waters Trading Up 0.9%

Shares of WAT opened at $322.38 on Friday. Waters Corporation has a twelve month low of $275.05 and a twelve month high of $414.15. The company has a current ratio of 1.73, a quick ratio of 1.01 and a debt-to-equity ratio of 0.37. The company has a market cap of $19.20 billion, a P/E ratio of 29.93, a P/E/G ratio of 2.20 and a beta of 1.18. The company’s fifty day simple moving average is $369.94 and its 200-day simple moving average is $349.92.

Waters (NYSE:WAT) last posted its quarterly earnings data on Monday, February 9th. The medical instruments supplier reported $4.53 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $4.50 by $0.03. The company had revenue of $932.36 million during the quarter, compared to analysts’ expectations of $928.17 million. Waters had a return on equity of 34.79% and a net margin of 20.30%.Waters’s revenue was up 6.9% compared to the same quarter last year. During the same quarter in the previous year, the business earned $4.10 EPS. Waters has set its FY 2026 guidance at 14.300-14.500 EPS and its Q1 2026 guidance at 2.250-2.350 EPS. As a group, analysts expect that Waters Corporation will post 12.86 EPS for the current year.

Analysts Set New Price Targets

A number of research firms have recently weighed in on WAT. UBS Group lowered their price objective on Waters from $395.00 to $370.00 and set a “neutral” rating on the stock in a research report on Tuesday, February 10th. Morgan Stanley lowered their price target on shares of Waters from $423.00 to $350.00 and set an “equal weight” rating on the stock in a report on Sunday. Bank of America reduced their price objective on shares of Waters from $410.00 to $350.00 and set a “neutral” rating for the company in a research note on Tuesday, February 10th. Citigroup initiated coverage on shares of Waters in a research note on Tuesday, February 10th. They set a “buy” rating and a $425.00 target price on the stock. Finally, Weiss Ratings reiterated a “hold (c)” rating on shares of Waters in a research note on Wednesday, January 21st. Two analysts have rated the stock with a Strong Buy rating, ten have assigned a Buy rating and nine have assigned a Hold rating to the company. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and a consensus price target of $393.84.

Waters Company Profile

Waters Corporation is a global provider of analytical instruments, software and services for laboratory and research applications. The company designs, manufactures and sells technologies centered on liquid chromatography, mass spectrometry, separation science, and related sample preparation and detection systems. Its product portfolio includes chromatographs, mass spectrometers, columns and consumables, laboratory informatics and workflow software, as well as technical support and training services that help customers run and interpret complex analyses.

Waters serves a wide range of end markets that include pharmaceutical and biotechnology companies, contract research and testing laboratories, academic and government research institutions, clinical diagnostics, food and environmental testing, and industrial and chemical manufacturers.